• News
  • SAN DIEGO
  • BioTech

Intrexon completes Medistem acquisition

Maryland-based Intrexon Corp. (NYSE: XON), a leader in synthetic biology, announced Friday that it has completed the acquisition of San Diego-based Medistem Inc. (OTC: MEDS).

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!